Resumo

LEACHE, L; SAIZ, LC; GUTIERREZ-VALENCIA, M  e  ERVITI, J. Transparency, equity and access to medicines: talking of the COVID-19 pandemic. Rev. OFIL·ILAPHAR [online]. 2020, vol.30, n.3, pp.185-188.  Epub 05-Abr-2021. ISSN 1699-714X.  https://dx.doi.org/10.4321/s1699-714x2020000300006.

The COVID-19 pandemic has generated a crisis at all levels, from health sector to the economic, working and social fields. Health systems have shown an enormous capacity to adapt to the needs, which have required rapid actions. To carry out an analysis of the situation is essential to resize needs and make a more efficient use of available resources with a view to the future. Some of the issues that will allow us to make progress in ensuring that the system remains sustainable and equitable are good quality scientific research with appropriate critical appraisal, prudence in medical practice, transparency and access to information, public investment in R+D+I, development of new drug financing models and international cooperation.

Palavras-chave : COVID-19; research; scientific evidence; drug; effectiveness; safety; regulation; transparency; accessibility; equity.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )